Related references
Note: Only part of the references are listed.Associations of Omega-3 Fatty Acid Supplement Use With Cardiovascular Disease Risks Meta-analysis of 10 Trials Involving 77 917 Individuals
Theingi Aung et al.
JAMA CARDIOLOGY (2018)
Fish-Derived Omega-3 Fatty Acids and Prostate Cancer: A Systematic Review
Monique Aucoin et al.
INTEGRATIVE CANCER THERAPIES (2017)
GRADE guidelines 17: assessing the risk of bias associated with missing participant outcome data in a body of evidence
Gordon H. Guyatt et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2017)
Effect of Omega-3 Acid Ethyl Esters on Left Ventricular Remodeling After Acute Myocardial Infarction The OMEGA-REMODEL Randomized Clinical Trial
Bobak Heydari et al.
CIRCULATION (2016)
Effects of Omega-3 fatty acid on major cardiovascular events and mortality in patients with coronary heart disease: A meta-analysis of randomized controlled trials
Y. T. Wen et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2014)
Addressing Dichotomous Data for Participants Excluded from Trial Analysis: A Guide for Systematic Reviewers
Elie A. Akl et al.
PLOS ONE (2013)
Efficacy of Omega-3 Fatty Acid Supplements (Eicosapentaenoic Acid and Docosahexaenoic Acid) in the Secondary Prevention of Cardiovascular Disease A Meta-analysis of Randomized, Double-blind, Placebo-Controlled Trials
Sang Mi Kwak et al.
ARCHIVES OF INTERNAL MEDICINE (2012)
GRADE guidelines 6. Rating the quality of evidence-imprecision
Gordon H. Guyatt et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2011)
Eicosapentaenoic acid (EPA) from highly concentrated n-3 fatty acid ethyl esters is incorporated into advanced atherosclerotic plaques and higher plaque EPA is associated with decreased plaque inflammation and increased stability
Abbie L. Cawood et al.
ATHEROSCLEROSIS (2010)
OMEGA, a Randomized, Placebo-Controlled Trial to Test the Effect of Highly Purified Omega-3 Fatty Acids on Top of Modern Guideline-Adjusted Therapy After Myocardial Infarction
Bernhard Rauch et al.
CIRCULATION (2010)
n-3 Fatty Acids and Cardiovascular Events after Myocardial Infarction
Daan Kromhout et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Effects of B vitamins and omega 3 fatty acids on cardiovascular diseases: a randomised placebo controlled trial
Pilar Galan et al.
BMJ-BRITISH MEDICAL JOURNAL (2010)
Comparison of low-fat versus Mediterranean-Style dietary intervention after first myocardial infarction (from the heart institute of Spokane diet intervention and evaluation trial)
Katherine R. Tuttle et al.
AMERICAN JOURNAL OF CARDIOLOGY (2008)
Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial
Luigi Tavazzi et al.
LANCET (2008)
GRADE:: what is quality of evidence and why is it important to clinicians?
Gordon H. Guyatt et al.
BMJ-BRITISH MEDICAL JOURNAL (2008)
Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised openlabel, blinded endpoint analysis
Mitsuhiro Yokoyama et al.
LANCET (2007)
Dioxins and polychlorinated biphenyls (PCBs) in fish oil dietary supplements: Occurrence and human exposure in the UK
A. R. Fernandes et al.
FOOD ADDITIVES AND CONTAMINANTS PART A-CHEMISTRY ANALYSIS CONTROL EXPOSURE & RISK ASSESSMENT (2006)
AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update - Endorsed by the National Heart, Lung, and Blood Institute
Sidney C. Smith et al.
CIRCULATION (2006)
An ω-3 polyunsaturated fatty acid concentrate increases plasma high-density lipoprotein 2 cholesterol and paraoxonase levels in patients with familial combined hyperlipidemia
L Calabresi et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2004)
Clinical outcome and atherothrombogenic risk profile after prolonged wash-out following long-term treatment with high doses of n-3 PUFAs in patients with an acute myocardial infarction
H Grundt et al.
CLINICAL NUTRITION (2004)
Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomised controlled trial
F Thies et al.
LANCET (2003)
Efficacy of n-3 polyunsaturated fatty acids after myocardial infarction: Results of GISSI-Prevenzione trial
R Marchioli et al.
LIPIDS (2001)
Share Paper
